title: Nodular regenerative hyperplasia: a new serious antiretroviral drugs side effect?
authors.forename: Pierre-Francois
authors.initials: PF
authors.lastname: Sandrine
authors.forename: Abel
authors.initials: A
authors.lastname: Sylvie
authors.forename: Edouard
authors.initials: E
authors.lastname: André
authors.forename: Diedhiou
authors.initials: D
authors.lastname: Abdoulaye
authors.forename: Liautaud
authors.initials: L
authors.lastname: Bernard
authors.forename: Cabie
authors.initials: C
authors.lastname: André
mesh_terms: D044966:Anti-Retroviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D056486:Chemical and Drug Induced Liver Injury; D016049:Didanosine / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D015497:HIV-1; D006801:Humans; D006965:Hyperplasia; D008099:Liver / Q000473:pathology; D008107:Liver Diseases / Q000188:drug therapy / Q000473:pathology; D008115:Liver Regeneration; D008875:Middle Aged; D019829:Nevirapine / Q000009:adverse effects / Q000627:therapeutic use; D015215:Zidovudine / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D044966:Anti-Retroviral Agents; D015215:Zidovudine; D019829:Nevirapine; D016049:Didanosine